UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Valvular heart disease and calcification in CKD: more common than appreciated

Nephrology, dialysis, transplantation, 2020-12, Vol.35 (12), p.2046-2053

2020

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Signature of Apolipoprotein J in the Early Phase of New-Onset Myocardial Infarction

Journal of proteome research, 2011-01, Vol.10 (1), p.211-220

2011

Link zum Volltext

Verfügbarkeit prüfen

A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study

Cardiovascular diagnosis and therapy, 2023-10, Vol.13 (5), p.777-791

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients

PloS one, 2014-07, Vol.9 (7), p.e102335-e102335

2014

Link zum Volltext

Verfügbarkeit prüfen

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study

International journal of hematology, 2011-04, Vol.93 (4), p.458-464

2011

Link zum Volltext

Verfügbarkeit prüfen

A comparative study of biomarkers for risk prediction in acute coronary syndrome—Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study

Atherosclerosis, 2010-10, Vol.212 (2), p.636-643

2010

Link zum Volltext

Verfügbarkeit prüfen

A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials

Expert review of cardiovascular therapy, 2024, Vol.22 (1-3), p.131-139

2024

Link zum Volltext

Verfügbarkeit prüfen

The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?

Journal of clinical pharmacy and therapeutics, 2020-10, Vol.45 (5), p.883-891

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of rivaroxaban in the prevention of atherosclerotic events

Expert review of clinical pharmacology, 2019-08, Vol.12 (8), p.771-780

2019

Link zum Volltext

Verfügbarkeit prüfen

Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

Expert review of clinical pharmacology, 2020-07, Vol.13 (7), p.695-706

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3554

2022

Link zum Volltext

Verfügbarkeit prüfen

Marcadores de inflamación y de antiinflamación en el síndrome coronario agudo: ¿listos para usarlos en la práctica clínica?

Revista española de cardiologia, 2005, Vol.58 (6), p.615-617

García-Moll, Xavier

2005

Link zum Volltext

Verfügbarkeit prüfen

Recommendations to improve the management and the prognosis of patients with heart failure

Future cardiology, 2020-01, Vol.16 (1), p.1-4

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention

The American journal of cardiology, 2014-05, Vol.113 (9), p.1487-1493

2014

Link zum Volltext

Verfügbarkeit prüfen

Demographic and Clinical Characteristics of Patients With Stable Coronary Artery Disease: Results From the CLARIFY Registry in Spain

Revista española de cardiología (English ed.), 2014-07, Vol.67 (7), p.538-544

2014

Link zum Volltext

Verfügbarkeit prüfen

Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology

International journal of molecular sciences, 2022-02, Vol.23 (4), p.2344

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum proteome in acute myocardial infarction

Clínica e investigación en arteriosclerosis, 2011-07, Vol.23 (4), p.147-154

2011

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3925

2023

Link zum Volltext

Verfügbarkeit prüfen

Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm

Drugs in context, 2021, Vol.10

2021

Link zum Volltext

Verfügbarkeit prüfen

Inflammation, atherosclerosis, classic cardiovascular risk factors, biostatistics, clinical significance. Where are we?

Revista española de cardiologia, 2007-12, Vol.60 (12), p.1220-1222

García-Moll, Xavier

2007

Link zum Volltext

Verfügbarkeit prüfen

On Contrast-Induced Acute Kidney Injury, Risk Prediction, and the Future of Predictive Model Development

Canadian journal of cardiology, 2017-06, Vol.33 (6), p.711-713

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(115)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Valvular heart disease and calcification in CKD: more common than appreciated

Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

Proteomic Signature of Apolipoprotein J in the Early Phase of New-Onset Myocardial Infarction

A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study

A comparative study of biomarkers for risk prediction in acute coronary syndrome—Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study

A cost-effectiveness analysis of empagliflozin for heart failure patients across the full spectrum of ejection fraction in Spain: combined results of the EMPEROR-Preserved and EMPEROR-Reduced trials

The use of sodium‐glucose co‐transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?

Role of rivaroxaban in the prevention of atherosclerotic events

Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study

Marcadores de inflamación y de antiinflamación en el síndrome coronario agudo: ¿listos para usarlos en la práctica clínica?

Recommendations to improve the management and the prognosis of patients with heart failure

Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention

Demographic and Clinical Characteristics of Patients With Stable Coronary Artery Disease: Results From the CLARIFY Registry in Spain

Rationale and design of perioperative myocardial ischemia: a protocol for troponin monitoring, prognostic thresholds, economic analysis and further insights into pathophysiology for non-cardiac surgery patients [version 1; peer review: 1 approved, 1 approved with reservations]

Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology

Serum proteome in acute myocardial infarction

Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm

Inflammation, atherosclerosis, classic cardiovascular risk factors, biostatistics, clinical significance. Where are we?

On Contrast-Induced Acute Kidney Injury, Risk Prediction, and the Future of Predictive Model Development

Suchergebnisse filtern